Laurence Dedeken

Université Libre de Bruxelles — Belgium

Medicine · Health Sciences

17h-index1.4kcitations76works19.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(42), Iron Metabolism and Disorders(24), Blood groups and transfusion(12), Prenatal Screening and Diagnostics(10), Acute Myeloid Leukemia Research(8)

Publications76 total

Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121
Blood·2025Open Access
Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience
Pediatric Blood & Cancer·2025Open Access
Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel
Blood Advances·2025Open Access
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet
Orphanet Journal of Rare Diseases·2025Open Access
Investigating Chromosomal Radiosensitivity in Inborn Errors of Immunity: Insights from DNA Repair Disorders and Beyond
Journal of Clinical Immunology·2025Open Access
Durable Clinical Benefits in Severe Sickle Cell Disease with Exagamglogene Autotemcel
Transplantation and Cellular Therapy·2025
Clinical and Morphological Bone Marrow Characteristics of Pearson Syndrome: About Three Consecutive Cases and Review of the Literature
Case Reports in Pediatrics·2025Open Access
Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease
Blood·2024· 2 citedOpen Access
Deciphering the Role and Therapeutic Potential of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia
Blood·2024
uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis
Blood·2024Open Access
Biomarkers of Hemolysis, Hemostasis, and Endothelial Activation Are Associated with Clinical Outcomes in Children with Sickle Cell Disease: An 8-Year Prospective Study
Blood·2024Open Access
COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet
2024Open Access
Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target
Pediatric Research·2024· 1 citedOpen Access
Exagamglogene Autotemcel for Severe Sickle Cell Disease
New England Journal of Medicine·2024· 306 cited
Elimination of Vaso-Occlusive Crises after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease
Transplantation and Cellular Therapy·2024· 2 cited
Pilot study on the use of basophil activation tests and skin tests for the prevention of allergic transfusion reactions
Frontiers in Allergy·2024· 1 citedOpen Access
Outcomes of Children with Sickle Cell Disease Born Outside Belgium Remain Different Compared to Those Born in Belgium Despite Similar Management
Blood·2023Open Access
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Blood·2023· 32 cited
P1427: RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY RADS IN EUROPE
HemaSphere·2023Open Access
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective
The Lancet Haematology·2023· 26 cited
page 1 of 4Next →

Frequent Co-authors

Alina Ferster(24), Phu-Quoc Lê(18), Cathérine Heijmans(18), Sophie Huybrechts(16), Christine Devalck(14), Laurence Rozen(13), An Van Damme(10), Marie‐Françoise Dresse(8), Barbara De Moerloose(8), Tim Lammens(8), Anne Uyttebroeck(8), Anna Vanderfaeillie(7), André Efira(7), Barbara Denys(6), Béatrice Gulbis(6), Barbara Depreter(6), Stephan Lobitz(5), Mariane de Montalembert(5), Fleur Samantha Benghiat(5), Denis F. Noubouossie(5)